van den Bosch F - Search Results

1

Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial.

van der Heijde D, Han C, DeVlam K, Burmester G, van den Bosch F, Williamson P, Bala M, Han J, Braun J. van der Heijde D, et al. Among authors: van den bosch f. Arthritis Rheum. 2006 Aug 15;55(4):569-74. doi: 10.1002/art.22097. Arthritis Rheum. 2006. PMID: 16874778 Free article. Clinical Trial.

2

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

Van Den Bosch F, Kruithof E, Baeten D, Herssens A, de Keyser F, Mielants H, Veys EM. Van Den Bosch F, et al. Arthritis Rheum. 2002 Mar;46(3):755-65. doi: 10.1002/art.511. Arthritis Rheum. 2002. PMID: 11920412 Free article. Clinical Trial.

3

Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.

De Rycke L, Kruithof E, Van Damme N, Hoffman IE, Van den Bossche N, Van den Bosch F, Veys EM, De Keyser F. De Rycke L, et al. Among authors: van damme n, van den bosch f, van den bossche n. Arthritis Rheum. 2003 Apr;48(4):1015-23. doi: 10.1002/art.10876. Arthritis Rheum. 2003. PMID: 12687543 Free article. Clinical Trial.

4

Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.

Vandooren B, Kruithof E, Yu DT, Rihl M, Gu J, De Rycke L, Van Den Bosch F, Veys EM, De Keyser F, Baeten D. Vandooren B, et al. Among authors: van den bosch f. Arthritis Rheum. 2004 Sep;50(9):2942-53. doi: 10.1002/art.20477. Arthritis Rheum. 2004. PMID: 15457463 Free article.

5

A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis.

Haringman JJ, Gerlag DM, Smeets TJ, Baeten D, van den Bosch F, Bresnihan B, Breedveld FC, Dinant HJ, Legay F, Gram H, Loetscher P, Schmouder R, Woodworth T, Tak PP. Haringman JJ, et al. Among authors: van den bosch f. Arthritis Rheum. 2006 Aug;54(8):2387-92. doi: 10.1002/art.21975. Arthritis Rheum. 2006. PMID: 16869001 Free article. Clinical Trial.

6

Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial.

Vergunst CE, Gerlag DM, Lopatinskaya L, Klareskog L, Smith MD, van den Bosch F, Dinant HJ, Lee Y, Wyant T, Jacobson EW, Baeten D, Tak PP. Vergunst CE, et al. Among authors: van den bosch f. Arthritis Rheum. 2008 Jul;58(7):1931-9. doi: 10.1002/art.23591. Arthritis Rheum. 2008. PMID: 18576354 Free article. Clinical Trial.

7

ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.

van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewé R; Assessment of SpondyloArthritis international Society (ASAS). van der Heijde D, et al. Among authors: van den bosch f. Ann Rheum Dis. 2009 Dec;68(12):1811-8. doi: 10.1136/ard.2008.100826. Epub 2008 Dec 5. Ann Rheum Dis. 2009. PMID: 19060001 Clinical Trial.

8

Etanercept in the longterm treatment of patients with ankylosing spondylitis.

Dijkmans B, Emery P, Hakala M, Leirisalo-Repo M, Mola EM, Paolozzi L, Salvarani C, Sanmarti R, Sibilia J, Sieper J, Van Den Bosch F, van der Heijde D, van der Linden S, Wajdula J. Dijkmans B, et al. Among authors: van der heijde d, van der linden s, van den bosch f. J Rheumatol. 2009 Jun;36(6):1256-64. doi: 10.3899/jrheum.081033. Epub 2009 May 1. J Rheumatol. 2009. PMID: 19411393 Clinical Trial.

9

Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome.

Boonen A, vander Cruyssen B, de Vlam K, Steinfeld S, Ribbens C, Lenaerts J, Van den Bosch F, Mielants H, Dewulf L, Vastesaeger N. Boonen A, et al. Among authors: van den bosch f. J Rheumatol. 2009 Jun;36(6):1249-55. doi: 10.3899/jrheum.080831. Epub 2009 May 15. J Rheumatol. 2009. PMID: 19447933

10

Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab.

Braun J, van der Heijde D, Doyle MK, Han C, Deodhar A, Inman R, de Vlam K, Burmester GR, Van den Bosch F, Xu S, Visvanathan S, Rahman MU. Braun J, et al. Among authors: van der heijde d, van den bosch f. Arthritis Rheum. 2009 Aug 15;61(8):1032-6. doi: 10.1002/art.24865. Arthritis Rheum. 2009. PMID: 19644896 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters